Neurogene Inc. (NASDAQ:NGNE) CEO Rachel Mcminn Buys 47,500 Shares
Neurogene Inc. (NASDAQ:NGNE – Get Free Report) CEO Rachel Mcminn purchased 47,500 shares of the company’s stock in a transaction on Friday, November 22nd. The shares were bought at an average price of $20.40 per share, with a total value of $969,000.00. Following the completion of the transaction, the chief executive officer now owns 1,297,859 […]
More Stories
Pitcairn Co. Acquires New Stake in iShares India 50 ETF (NASDAQ:INDY)
Pitcairn Co. bought a new stake in iShares India 50 ETF (NASDAQ:INDY – Free Report) during the third quarter, according...
Pitcairn Co. Sells 540 Shares of Enpro Inc. (NYSE:NPO)
Pitcairn Co. lessened its position in Enpro Inc. (NYSE:NPO – Free Report) by 12.3% in the third quarter, according to...
Pitcairn Co. Has $601,000 Stake in Omnicom Group Inc. (NYSE:OMC)
Pitcairn Co. boosted its holdings in Omnicom Group Inc. (NYSE:OMC – Free Report) by 20.4% in the 3rd quarter, HoldingsChannel.com...
Pitcairn Co. Has $642,000 Position in The Charles Schwab Co. (NYSE:SCHW)
Pitcairn Co. decreased its holdings in shares of The Charles Schwab Co. (NYSE:SCHW – Free Report) by 18.9% in the...
Algert Global LLC Raises Stake in Methode Electronics, Inc. (NYSE:MEI)
Algert Global LLC increased its position in shares of Methode Electronics, Inc. (NYSE:MEI – Free Report) by 228.2% during the...
Pitcairn Co. Decreases Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX)
Pitcairn Co. decreased its stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report) by 13.6% in the third quarter, according...